Alnylam Pharmaceuticals
ALNY
#689
Rank
A$52.92 B
Marketcap
A$396.39
Share price
-1.64%
Change (1 day)
-17.49%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company